prescription retatrutide for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide: The New Triple-Agonist Weight

Current anesthesia care guidance for diabetic patients taking GLP-1 agonists Lets examine the 2023 consensus-based practice guidelines published by the ASA regarding the anesthetic considerations of the GLP-1RAs: GLP-1 agonists are associated with many adverse effects, such as nausea, vomiting, delayed gastric emptying, and abdominal pain and bloating

A total of 9340 participants with a high CV risk, who were 50 years of age, with HbA1c 7% were randomly assigned to receive placebo or liraglutide (1.8 mg)

Examples of effective anchors: Morning injectors: "After I brush my teeth and before I make coffee" or "Right after my alarm goes off, before I check my phone." Evening injectors: "Right after I brush my teeth for bed" or "Immediately after I put the kids to sleep." The key is specificity

In terms of safety and tolerability, the adverse events were primarily mild to moderate gastrointestinal reactions, with no reports of severe hypoglycemia or death